[CAS NO. 357166-30-4]  Pemetrexed Disodium Hydrate

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [357166-30-4]

Fulfillment
Catalog
SLK-S7785
Brand
Selleck
CAS
357166-30-4

DESCRIPTION [357166-30-4]

Overview

MDLMFCD08458870
Molecular Weight516.42
Molecular FormulaC20H21N5O6.5/2H2O.2Na
SMILESO=C1C2=C(NC=C2CCC3=CC=C(C=C3)C(N[C@@H](CCC([O-])=O)C([O-])=O)=O)NC(N)=N1.O=C4C5=C(NC=C5CCC6=CC=C(C=C6)C(N[C@@H](CCC([O-])=O)C([O-])=O)=O)NC(N)=N4.[Na+].[Na+].[Na+].[Na+].O.O.O.O.O

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.9364 mL9.6820 mL19.3641 mL
5 mM0.3873 mL1.9364 mL3.8728 mL
10 mM0.1936 mL0.9682 mL1.9364 mL
50 mM0.0387 mL0.1936 mL0.3873 mL

Description

Pemetrexed Disodium Hydrate (LY-231514) is a novel antifolate and antimetabolite for TS, and GARFT with of 1.3 nM, 7.2 nM and 65 nM, respectively. Pemetrexed Disodium Hydrate stimulates and .

Targets

TS [1]DHFR [1]GARFT [1]
1.3 nM(Ki)7.2 nM(Ki)65 nM(Ki)

In vitro

Pemetrexed disodium shows the antiproliferative activity in CCRF-CEM leukemia, GC3/C1 colon carcinoma, and HCT-8 ileocecal carcinoma cells with IC50 of 25 nM, 34 nM and 220 nM, respectively. A recent study shows that cisplatin plus Pemetrexed combined with SOCS-1 gene delivery shows the antitumor effect by inhibition of cell proliferation, invasiveness, and induction of apoptosis in MPM cells infected with adenovirus-expressing SOCS-1 vector.

In vivo

In the human H460 non-small cell lung carcinoma xenograft, Pemetrexed disodium produces a duration-dependent tumor growth delay (TGD).